Results 231 to 240 of about 192,841 (253)

Aflibercept in real-life for the treatment of age-related macular degeneration using a treat and extend protocol: The Armada study

European Journal of Ophthalmology, 2022
Pierre Gascón, Prithvi Ramtohul, Sébastien Kerever   +2 more
exaly  

Results of Switching from Pro Re Nata to Treat-and-Extend Regimen in Treatment of Patients with Type 3 Neovascularization

Seminars in Ophthalmology, 2020
Jae Hui Kim
exaly  

Comparison of Two Different Treat-and-Extend Protocols with Aflibercept in Wet Age-Related Macular Degeneration: Two-Year Results

Advances in Therapy, 2020
Claudia Taipale, Juha-Matti Lindholm, Kai Kaarniranta   +2 more
exaly  

Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration

Ophthalmology, 2018
Rufino Silva, András Berta, Michael Larsen   +2 more
exaly  

Comparison of two different treat‐and‐extend protocols with aflibercept in wet age‐related macular degeneration

Acta Ophthalmologica, 2020
Claudia Taipale, Juha-Matti Lindholm, Ilkka Laine   +2 more
exaly  

Two-Year Outcomes of “Treat and Extend” Intravitreal Therapy for Neovascular Age-Related Macular Degeneration

Ophthalmology, 2015
Jennifer J Arnold, Anna Campain, Daniel Barthelmes   +2 more
exaly  

Canadian Treat-and-Extend Analysis Trial with Ranibizumab in Patients with Neovascular Age-Related Macular Disease

Ophthalmology, 2019
Peter J Kertes, R Geoff Williams, Emmanouil Rampakakis   +2 more
exaly  

Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema

Ophthalmology, 2017
John F Payne, Charles C Wykoff, W Lloyd Clark   +2 more
exaly  

Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration

Ophthalmology, 2015
Charles C Wykoff, Daniel E Croft, David M Brown   +2 more
exaly  

Treat and Extend Analysis Trial With Aflibercept in Wet-AMD

Case Medical Research, 2019
openaire   +1 more source